Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
- June -
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
- 2023 -
2024
-
2025
June 2023 - 50 products
IP
CI
DorzoComp-Vision SDU 20
mg/ml + 5mg/ml
60 x 0.2 ml
19.78
37.95
10 %
Eye drops: 2 Active Agents
OmniVision AG
B / SL / SG
FB
G
IP
CI
DorzoComp-Vision SDU 20
mg/ml + 5mg/ml
120 x 0.2 ml
37.58
57.30
10 %
Eye drops: 2 Active Agents
OmniVision AG
B / SL / SG
FB
G
L
IP
CI
Pitavastatin Spirig HC 1 mg
30
21.17
39.40
10 %
Coated tablets: Pitavastatinum 1 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Pitavastatin Spirig HC 1 mg
90
63.50
85.35
10 %
Coated tablets: Pitavastatinum 1 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Pitavastatin Spirig HC 2 mg
30
25.76
44.40
10 %
Coated tablets: Pitavastatinum 2 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Pitavastatin Spirig HC 2 mg
90
77.30
100.35
10 %
Coated tablets: Pitavastatinum 2 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Pitavastatin Spirig HC 4 mg
30
37.38
57.00
10 %
Coated tablets: Pitavastatinum 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Pitavastatin Spirig HC 4 mg
90
112.14
138.20
10 %
Coated tablets: Pitavastatinum 4 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
CI
Dabigatran Sandoz 110 mg
60
40.97
60.95
10 %
Capsules: Dabigatranum Etexilatum 110 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Dabigatran Sandoz 110 mg
180
122.90
150.10
10 %
Capsules: Dabigatranum Etexilatum 110 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Dabigatran Sandoz 150 mg
60
40.97
60.95
10 %
Capsules: Dabigatranum Etexilatum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Dabigatran Sandoz 150 mg
180
122.90
150.10
10 %
Capsules: Dabigatranum Etexilatum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Tizanidin axapharm 2 mg
30
4.61
14.25
10 %
Tablets: Tizanidinum 2 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Tizanidin axapharm 2 mg
100
13.22
30.80
10 %
Tablets: Tizanidinum 2 mg
axapharm ag
B / SL / SG
FB
G
IP
Tizanidin axapharm 4 mg
10
2.93
12.40
10 %
Tablets: Tizanidinum 4 mg
axapharm ag
B / SL / SG
FB
G
IP
Tizanidin axapharm 4 mg
30
7.28
17.15
10 %
Tablets: Tizanidinum 4 mg
axapharm ag
B / SL / SG
FB
G
IP
Tizanidin axapharm 4 mg
100
23.12
41.55
10 %
Tablets: Tizanidinum 4 mg
axapharm ag
B / SL / SG
FB
G
L
IP
CI
AMVUTTRA®
98740.37
101615.40
10 %
Alnylam Switzerland
GmbH
B / SL
FB
G
L
IP
Nplate 125 mcg
252.27
290.75
10 %
Dry substance: Romiplostimum 125 µg
Amgen Switzerland AG
A / SL
FB
G
IP
CI
Prednison Spirig HC 1 mg
20
1.65
11.05
10 %
Tablets: Prednisonum 1 mg
Spirig HealthCare AG
B / SL
FB
G
IP
CI
Prednison Spirig HC 1 mg
100
3.80
13.35
10 %
Tablets: Prednisonum 1 mg
Spirig HealthCare AG
B / SL
FB
G
IP
Prednison Spirig HC 5 mg
20
2.10
11.50
10 %
Tablets: Prednisonum 5 mg
Spirig HealthCare AG
● 
B / SL
FB
G
IP
Prednison Spirig HC 5 mg
100
6.90
16.75
10 %
Tablets: Prednisonum 5 mg
Spirig HealthCare AG
● 
B / SL
FB
G
IP
Prednison Spirig HC 20 mg
20
4.75
14.40
10 %
Tablets: Prednisonum 20 mg
Spirig HealthCare AG
B / SL
FB
G
IP
Prednison Spirig HC 20 mg
100
15.55
33.35
10 %
Tablets: Prednisonum 20 mg
Spirig HealthCare AG
B / SL
FB
G
IP
Prednison Spirig HC 50 mg
20
8.75
25.95
10 %
Tablets: Prednisonum 50 mg
Spirig HealthCare AG
B / SL
FB
G
IP
Enjaymo 1100 mg/22 ml
22 ml
PR
PR
k.A.
Infusion solution: Sutimlimabum 50 mg/ml
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Enjaymo 1100 mg/22 ml
6 x 22 ml
PR
PR
k.A.
Infusion solution: Sutimlimabum 50 mg/ml
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Dexmedetomidin Fresenius
i.v. 200ug/2ml
10
PR
PR
k.A.
Concentrate for infusion: Dexmedetomidinum 200µg / 2ml
Fresenius Kabi
(Schweiz) AG
A
FB
G
IP
Dexmedetomidin Fresenius
i.v. 400ug/4ml
10
PR
PR
k.A.
Concentrate for infusion: Dexmedetomidinum 400µg / 4ml
Fresenius Kabi
(Schweiz) AG
A
FB
G
IP
Dexmedetomidin Fresenius
i.v. 1000ug/10ml
10
PR
PR
k.A.
Concentrate for infusion: Dexmedetomidinum 1000µg / 10ml
Fresenius Kabi
(Schweiz) AG
A
FB
G
Apixaban-Mepha 2.5 mg
20
PR
PR
k.A.
Coated tablets: Apixabanum 2.5 mg
Mepha Pharma AG
B
FB
G
Apixaban-Mepha 2.5 mg
56
PR
PR
k.A.
Coated tablets: Apixabanum 2.5 mg
Mepha Pharma AG
B
FB
G
Apixaban-Mepha 2.5 mg
100
PR
PR
k.A.
Coated tablets: Apixabanum 2.5 mg
Mepha Pharma AG
B
FB
G
Apixaban-Mepha 2.5 mg
168
PR
PR
k.A.
Coated tablets: Apixabanum 2.5 mg
Mepha Pharma AG
B
FB
G
Apixaban-Mepha 5 mg
56
PR
PR
k.A.
Coated tablets: Apixabanum 5 mg
Mepha Pharma AG
B
FB
G
Apixaban-Mepha 5 mg
100
PR
PR
k.A.
Coated tablets: Apixabanum 5 mg
Mepha Pharma AG
B
FB
G
Apixaban-Mepha 5 mg
168
PR
PR
k.A.
Coated tablets: Apixabanum 5 mg
Mepha Pharma AG
B
FB
G
IP
Vafseo 150 mg
28
PR
PR
k.A.
Coated tablets: Vadadustatum 150 mg
Salmon Pharma GmbH
A
FB
G
IP
Vafseo 150 mg
98
PR
PR
k.A.
Coated tablets: Vadadustatum 150 mg
Salmon Pharma GmbH
A
FB
G
IP
Vafseo 300 mg
28
PR
PR
k.A.
Coated tablets: Vadadustatum 300 mg
Salmon Pharma GmbH
A
FB
G
IP
Vafseo 300 mg
98
PR
PR
k.A.
Coated tablets: Vadadustatum 300 mg
Salmon Pharma GmbH
A
FB
G
IP
Vafseo 450 mg
28
PR
PR
k.A.
Coated tablets: Vadadustatum 450 mg
Salmon Pharma GmbH
A
FB
G
IP
Vafseo 450 mg
98
PR
PR
k.A.
Coated tablets: Vadadustatum 450 mg
Salmon Pharma GmbH
A
FB
G
IP
CI
CM
Afelor Liquid Caps 200 mg
10
PR
PR
k.A.
Soft capsules: Ibuprofenum 200 mg
NOBEL Pharma Schweiz AG
D
FB
G
IP
CM
Afelor Liquid Caps forte 400 mg
10
PR
PR
k.A.
Soft capsules: Ibuprofenum 400 mg
NOBEL Pharma Schweiz AG
D
FB
G
Efmody 5 mg
50
PR
PR
k.A.
Hartkapseln mit veränderter Wirkstofffreisetzung: Hydrocortisonum 5 mg
EffRx Pharmaceuticals SA
B
FB
G
Efmody 10 mg
50
PR
PR
k.A.
Hartkapseln mit veränderter Wirkstofffreisetzung: Hydrocortisonum 10 mg
EffRx Pharmaceuticals SA
B
FB
G
IP
CI
Ciclopirox LEMAN 8%
3.3 ml
PR
PR
k.A.
Vernis à ongles médicamenteux: Ciclopiroxum 80 mg
Leman SKL SA
B
FB
G
IP
CI
Ciclopirox LEMAN 8%
6.6 ml
PR
PR
k.A.
Vernis à ongles médicamenteux: Ciclopiroxum 80 mg
Leman SKL SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home